DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Zinman B, Wanner C, Lachin JM. et al.
Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes.
The New England Journal of Medicine 2015; 373. doi: 10.1056/NEJMoa1504720
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.